[患有ATP6V1A基因变异的患者的遗传和临床特征]
S J Ouyang1, T Wang1, Q Z Tan1
1Children's Medical Center, Peking University First Hospital, Beijing 102627, China.
这项研究表明,ATP6V1A基因变异与儿童有关,经常导致发育迟缓和特定的发作类型,如焦点发作和发作. 大多数变体都是de novo,治疗结果各不相同.
科学领域:
- 遗传学 遗传学 是一个
- 神经学 神经学
- 儿科 儿科 儿科
背景情况:
- 是一种神经系统疾病,其特点是经常性发作.
- 遗传因素在病的病因学中起着重要作用,特别是在早期发病的形式中.
- 编码V-ATPase的一个子单元的ATP6V1A基因与罕见的神经发育障碍有关.
研究的目的:
- 调查与儿童ATP6V1A基因异合体变异相关的的遗传和临床特征.
- 分析受影响个体的临床表型,发作类型和治疗反应的范围.
主要方法:
- 一个涉及10名患有ATP6V1A基因变异和的儿童的案例系列研究.
- 临床数据收集包括遗传分析,特征,发育评估,EEG,MRI和治疗结果.
- 分析的重点是基因型-表型相关性和预后因素.
主要成果:
- 所有10名儿童都有新的异合的ATP6V1A变体 (1个马赛克);7个是新鲜的.
- 发作发生在28个月的中位年龄,焦点发作和发作是常见的.
- 在8名儿童中观察到全球发育迟缓;5名儿童被诊断为发育性和性脑病变 (DEE).
结论:
- ATP6V1A基因变异与一系列现象相关,包括DEE和婴儿发作综合征.
- 现型呈现是可变的,大多数患者表现出发育迟缓,但少数人保持正常发育.
- 这些发现凸显了ATP6V1A的基因检测在患有不明原因和发育问题的儿童中的重要性.
更多相关视频
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
06:58A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
Published on: July 12, 2021
相关概念视频
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
ATP Synthase: Mechanism
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
